MedPath

Effects of Music Intervention Combined With Progressive Muscle Relaxation in Cancer Patients

Not Applicable
Completed
Conditions
Cancer
Interventions
Other: progressive muscle relaxation
Other: Listening to relaxing music once/day
Registration Number
NCT05262621
Lead Sponsor
The Nethersole School of Nursing
Brief Summary

Study design A 2-arm, assessor-blinded randomised controlled trial will be conducted. The design will follow the Standard Protocol Items Recommendations for Interventional Trials (SPIRIT)

Detailed Description

Aim: To assess the effect of MCP on anxiety, depression and QoL of BGC patients receiving chemotherapy.

Objectives

* To assess the effect of MCP on the anxiety of BGC patients receiving chemotherapy.

* To assess the effect of MCP on depression of BGC patients receiving chemotherapy.

* To assess the effect of MCP on QoL and patients' satisfaction of BGC patients receiving chemotherapy.

* To determine whether stress level, coping and coping styles mediate the intervention effect on anxiety, depression and QoL.

Hypothesis

* The participants receiving MCP will have a significantly lower level of anxiety compared to the control group.

* The participants receiving MCP will have a significantly lower level of depression compared to the control group.

* The participants receiving MCP will have significantly higher QoL scores and levels of satisfaction with care service compared to the control group.

* Stress level, coping will mediate the intervention on target outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
84
Inclusion Criteria
  • Women with breast or gynaecological cancer are 18 years of age or older, and are independent legally to sign the consent form.
  • Living with family and having an adult family member agree to participate in the meeting part of the program.
  • Had been informed the cancer diagnosis
  • Have Karnofsky score (Mor et al., 1984) ≥ 80 ( to be able to self-practice MCP)
  • Can communicate, read and write in Vietnamese
  • Have a device such as a smartphone, MP3 to keep the audio file (to self-practice MCP at home)
  • Consent to join the study
Exclusion Criteria
  • The patients cannot understand the study procedures
  • Have mental health illness, deafness, blindness
  • Have not been aware of their cancer or the purpose of chemotherapy
  • Be participating in other studies related to psychological issues
  • Be receiving anxiety or depression treatment.
  • Be participating in relaxation therapy such as yoga, meditation, mindfulness, PMR...
  • Have a potential treatment (eg. surgery) or personal plans that will prevent them from practising daily during the 6 weeks of the intervention.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Music intervention combined with progressive muscle relaxationprogressive muscle relaxationMusic intervention combined with progressive muscle relaxation.
Music intervention combined with progressive muscle relaxationListening to relaxing music once/dayMusic intervention combined with progressive muscle relaxation.
Primary Outcome Measures
NameTimeMethod
Change from baseline anxiety at 3 weeks and 6 weeksebaseline, T1 after 3 weeks, T2 after 6 weeks

it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for anxiety (DASS21-A). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the anxiety score can range from 0 to 42. The higher the score is the more severe anxiety. The score of 0-7 is normal, 8-9 mild, 10-14 moderate, 15-19 severe, +20 extremely severe.

Change from baseline depression at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeks

it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for depression (DASS21-D). A 4-point Likert-type scale ranging from 0 to 3 was designed on each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the depression score can range from 0 to 42. The higher the score is the more severe depression. The score of 0-9 is normal, 10-13 mild, 14-20 moderate, 21-27 severe, +28 extremely severe.

Secondary Outcome Measures
NameTimeMethod
Change from baseline quality of life at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeks

coping will be measured using FACT-G.It evaluates in functional scales on Social/family well-being (SWB); Emotional well-being (EWB) and Functional well-being (FWB). Each item is scored in one of five categories of 0-4, with 'Not at all', 'A little bit', 'some what', 'Quite a bit' 'Very much'. The higher the score is the better quality of life." The possible range of scores is from 0 to 112.

Change from baseline stress at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeks

it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for stress (DASS21-S). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the stress score can range from 0 to 42. The higher the score is the more severe stress. The score of 0-14 is normal, 15-18 mild, 19-25 moderate, 26-33 severe, +34 extremely severe.

Change from baseline coping styles at 3 weeks and 6 weeksbaseline, T1 after 3 weeks, T2 after 6 weeks

Coping will be measured using Brief COPE. The Brief-COPE is a 28 item self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event.The scale can determine someone's primary coping styles with scores on the following three subscale:

Problem-Focussed Coping, Emotion-Focussed Coping, Avoidant Coping.A 4-point Likert-type scale ranging from 1 to 4 was designed on each item.

Change from baseline satisfaction of nursing care at 3 weeksbaseline, T1 after 3 weeks,

satisfaction of nursing care will be measured using numerical rating scale.(0-10) from 0 = completely dissatisfied with the care to 10 = completely satisfied with the care.

Trial Locations

Locations (1)

Vietnam National Cancer Institute, Hanoi Oncology Hospital

🇻🇳

Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath